Retrospective Evaluation of the Analgesic Effects of Molecular Target Agents Against Cancer Pain and Oxaliplatin-Induced Chronic Peripheral Neuropathy. (2022). Journal of Analytical Oncology, 11, 40-44. https://doi.org/10.30683/1927-7229.2022.11.06